DOLUTEGRAVIR SODIUM AND LAMIVUDINE

DOLUTEGRAVIR SODIUM AND LAMIVUDINE was reported 3600 times

DOLUTEGRAVIR SODIUM AND LAMIVUDINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CYSTOSTOMY 15 0.2679
1 PROCTITIS CHLAMYDIAL 2 0.1818
2 PROCTITIS BACTERIAL 2 0.1250
3 SYPHILIS TEST POSITIVE 3 0.1000
4 CD4 LYMPHOCYTE PERCENTAGE DECREASED 4 0.0909
5 FISTULOTOMY 2 0.0741
6 BLADDER ULCER 3 0.0732
7 HORMONE-DEPENDENT PROSTATE CANCER 5 0.0714
8 BLOOD ELASTASE DECREASED 1 0.0556
9 MONKEYPOX 15 0.0543
10 BLOOD HIV RNA INCREASED 82 0.0452
11 HYPERANDROGENISM 4 0.0426
12 CONGENITAL GENITAL MALFORMATION 6 0.0375
13 CARDIOVASCULAR FUNCTION TEST ABNORMAL 1 0.0370
14 PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT 32 0.0366
15 INTERFERON GAMMA RELEASE ASSAY POSITIVE 6 0.0366
16 VIRILISM 4 0.0364
17 HYPOTELORISM OF ORBIT 2 0.0357
18 SYPHILIS 25 0.0344
19 PENILE DERMATITIS 2 0.0317
20 VIRAL LOAD INCREASED 121 0.0311
21 GONOCOCCAL INFECTION 2 0.0290
22 VIRAL LOAD ABNORMAL 5 0.0286
23 SCHISTOSOMIASIS 2 0.0260
24 DOUBLE URETER 1 0.0250
25 ANAL BLISTER 1 0.0250
26 CONGENITAL SKIN DIMPLES 6 0.0249
27 BONE DEMINERALISATION 26 0.0246
28 DUODENAL ATRESIA 3 0.0244
29 CONGENITAL TERATOMA 2 0.0233
30 VIRAL MUTATION IDENTIFIED 82 0.0222
31 CEREBRAL AMYLOID ANGIOPATHY 7 0.0212
32 ANAL NEOPLASM 1 0.0204
33 SECONDARY SYPHILIS 2 0.0202
34 TOXIC NEUROPATHY 7 0.0178
35 ACUTE CARDIAC EVENT 3 0.0174
36 CD8 LYMPHOCYTES INCREASED 1 0.0161
37 BILE OUTPUT ABNORMAL 1 0.0154
38 CD4 LYMPHOCYTES DECREASED 32 0.0149
39 BETA 2 MICROGLOBULIN URINE INCREASED 2 0.0140
40 RENAL HYPOPLASIA 3 0.0138
41 PATHOGEN RESISTANCE 119 0.0130
42 PRIMARY BILIARY CHOLANGITIS 6 0.0128
43 VIROLOGIC FAILURE 68 0.0126
44 KIDNEY DUPLEX 3 0.0125
45 HOLOPROSENCEPHALY 2 0.0124
46 CONGENITAL RENAL DISORDER 3 0.0113
47 FACIAL WASTING 3 0.0112
48 VITAMIN B12 ABNORMAL 2 0.0102
49 HERPES SIMPLEX TEST POSITIVE 2 0.0101
50 CD4 LYMPHOCYTES ABNORMAL 2 0.0095
51 CHRONIC HEPATITIS B 3 0.0095
52 UPPER RESPIRATORY TRACT INFECTION BACTERIAL 2 0.0093
53 HEPATITIS ALCOHOLIC 3 0.0092
54 VIRAEMIA 12 0.0087
55 TYPE IIA HYPERLIPIDAEMIA 2 0.0085
56 DERMATOPHYTOSIS OF NAIL 1 0.0084
57 ABORTION OF ECTOPIC PREGNANCY 1 0.0083
58 SLEEVE GASTRECTOMY 2 0.0081
59 PRODUCT DOSE OMISSION IN ERROR 224 0.0079
60 BALANITIS CANDIDA 1 0.0078
61 KERATOMILEUSIS 2 0.0078
62 BRONCHIAL HYPERREACTIVITY 9 0.0075
63 DISEASE RISK FACTOR 3 0.0075
64 GONORRHOEA 2 0.0074
65 SOLAR DERMATITIS 2 0.0074
66 T-LYMPHOCYTE COUNT DECREASED 5 0.0073
67 ENCEPHALOMYELITIS 2 0.0073
68 HELICOBACTER GASTRITIS 9 0.0073
69 MONOCLONAL IMMUNOGLOBULIN INCREASED 2 0.0070
70 ANOGENITAL DYSPLASIA 1 0.0067
71 HYPNAGOGIC HALLUCINATION 2 0.0066
72 CALCULUS URETHRAL 1 0.0065
73 SALPINGITIS 2 0.0063
74 PLASTIC SURGERY 2 0.0062
75 GASTROENTERITIS BACTERIAL 2 0.0061
76 VASCULAR PURPURA 8 0.0057
77 GASTROINTESTINAL MICROORGANISM OVERGROWTH 2 0.0057
78 ACUTE HEPATITIS C 1 0.0055
79 HEPATITIS B 31 0.0051
80 GENITAL LESION 2 0.0047
81 SPINAL CORD INFECTION 3 0.0046
82 CORNEAL INFECTION 1 0.0046
83 SOCIAL ANXIETY DISORDER 3 0.0046
84 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 1 0.0045
85 GASTRIC FISTULA 2 0.0045
86 HEPATITIS B DNA INCREASED 3 0.0045
87 CREATININE RENAL CLEARANCE ABNORMAL 2 0.0043
88 CD4 LYMPHOCYTES INCREASED 1 0.0043
89 PLICATED TONGUE 2 0.0042
90 CANCER IN REMISSION 1 0.0041
91 TYPE V HYPERLIPIDAEMIA 2 0.0041
92 BODY MASS INDEX ABNORMAL 1 0.0041
93 RETROGRADE AMNESIA 2 0.0040
94 ANAL INFECTION 1 0.0039
95 INTENTIONAL DOSE OMISSION 109 0.0038
96 CONGENITAL NOSE MALFORMATION 2 0.0038
97 EXOMPHALOS 2 0.0037
98 PRODUCT DOSE OMISSION ISSUE 1096 0.0037
99 MEASLES 2 0.0037
100 MOLLUSCUM CONTAGIOSUM 2 0.0037
101 MORNING SICKNESS 2 0.0037
102 ANHEDONIA 95 0.0036
103 DYSPRAXIA 2 0.0035
104 HEPATITIS A 3 0.0035
105 ANOGENITAL WARTS 3 0.0034
106 THYROID CYST 2 0.0034
107 STAPHYLOCOCCAL SEPSIS 16 0.0032
108 BIOPSY BREAST 1 0.0032
109 ASOCIAL BEHAVIOUR 1 0.0031
110 COLORECTAL ADENOMA 1 0.0031
111 DISCONTINUED PRODUCT ADMINISTERED 1 0.0030
112 HIV TEST POSITIVE 2 0.0030
113 DEFAECATION DISORDER 2 0.0030
114 TESTICULAR DISORDER 3 0.0030
115 PROSTATITIS 9 0.0030
116 ALCOHOLIC LIVER DISEASE 1 0.0029
117 ASTHMA EXERCISE INDUCED 1 0.0029
118 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 3 0.0028
119 ANTIDEPRESSANT DRUG LEVEL INCREASED 1 0.0028
120 HYPERTENSIVE NEPHROPATHY 3 0.0028
121 LIPIDS ABNORMAL 2 0.0028
122 PALMOPLANTAR KERATODERMA 2 0.0028
123 DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION 1 0.0028
124 CREATININE RENAL CLEARANCE INCREASED 2 0.0027
125 INDIFFERENCE 2 0.0027
126 OESOPHAGEAL DISCOMFORT 2 0.0026
127 SOFT TISSUE INJURY 2 0.0026
128 COMPLICATION OF PREGNANCY 2 0.0026
129 GENITAL ULCERATION 2 0.0026
130 MICTURITION DISORDER 9 0.0026
131 HEPATITIS B REACTIVATION 8 0.0025
132 OSTEOPENIA 38 0.0025
133 LIPIDS INCREASED 5 0.0025
134 SPUTUM CULTURE POSITIVE 2 0.0025
135 PERITONEAL DIALYSIS 2 0.0024
136 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 12 0.0024
137 PRODUCT COMMUNICATION ISSUE 21 0.0024
138 GASTRIC ULCER PERFORATION 3 0.0024
139 ADJUSTMENT DISORDER 3 0.0023
140 AUTOIMMUNE HEPATITIS 16 0.0023
141 FANCONI SYNDROME ACQUIRED 4 0.0023
142 DEGENERATIVE BONE DISEASE 1 0.0023
143 ABDOMINAL NEOPLASM 2 0.0022
144 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 1 0.0022
145 DYSLIPIDAEMIA 11 0.0022
146 SELF-INJURIOUS IDEATION 9 0.0021
147 ATYPICAL MYCOBACTERIAL INFECTION 3 0.0021
148 LIPOATROPHY 2 0.0021
149 ANAL CANCER 2 0.0021
150 LYMPHADENECTOMY 2 0.0020
151 ARTIFICIAL CROWN PROCEDURE 1 0.0020
152 MARASMUS 3 0.0020
153 GENITAL HERPES 3 0.0020
154 ACUTE INTERSTITIAL PNEUMONITIS 1 0.0019
155 SINUS ARREST 3 0.0019
156 LATENT TUBERCULOSIS 4 0.0019
157 URETEROLITHIASIS 2 0.0019
158 TINEA PEDIS 3 0.0019
159 ACARODERMATITIS 2 0.0018
160 BURNING MOUTH SYNDROME 1 0.0018
161 METABOLIC SURGERY 2 0.0018
162 MACROCYTOSIS 2 0.0017
163 INABILITY TO AFFORD MEDICATION 17 0.0017
164 TREATMENT NONCOMPLIANCE 90 0.0016
165 TOOTH EROSION 2 0.0016
166 POST PROCEDURAL INFECTION 13 0.0016
167 GLUCOSE URINE PRESENT 2 0.0016
168 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
169 INTENTIONAL UNDERDOSE 11 0.0015
170 BONE DEFORMITY 1 0.0015
171 NEUROTOXICITY 26 0.0015
172 GLYCOSURIA 2 0.0015
173 ANGULAR CHEILITIS 1 0.0014
174 BRAIN CANCER METASTATIC 1 0.0014
175 DISCHARGE 2 0.0014
176 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 256 0.0014
177 FANCONI SYNDROME 2 0.0014
178 OSTEOPOROSIS 58 0.0014
179 LABELLED DRUG-DRUG INTERACTION ISSUE 2 0.0014
180 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
181 BIPOLAR I DISORDER 3 0.0014
182 SLEEP PARALYSIS 2 0.0014
183 BENIGN PROSTATIC HYPERPLASIA 7 0.0014
184 GENITAL PAIN 2 0.0014
185 FOETAL DEATH 7 0.0013
186 IMPETIGO 2 0.0013
187 HIV INFECTION 4 0.0013
188 BONE DENSITY DECREASED 41 0.0013
189 DEBRIDEMENT 1 0.0013
190 HAEMANGIOMA 3 0.0013
191 SUBSTANCE USE 2 0.0013
192 STRONGYLOIDIASIS 2 0.0012
193 PITUITARY TUMOUR BENIGN 2 0.0012
194 ANAL ULCER 1 0.0012
195 SHOULDER FRACTURE 2 0.0012
196 METABOLIC SYNDROME 2 0.0012
197 HYPERURICAEMIA 5 0.0012
198 SEBORRHOEIC DERMATITIS 2 0.0012
199 MEAN CELL HAEMOGLOBIN INCREASED 2 0.0012
200 GASTRIC DILATATION 2 0.0012
201 HYPERTRIGLYCERIDAEMIA 7 0.0012
202 CONGENITAL CYSTIC KIDNEY DISEASE 1 0.0012
203 INTERVERTEBRAL DISC DISORDER 5 0.0012
204 COLONIC ABSCESS 1 0.0012
205 HELICOBACTER INFECTION 12 0.0012
206 ALLERGIC SINUSITIS 1 0.0012
207 FUNCTIONAL GASTROINTESTINAL DISORDER 4 0.0012
208 OTORRHOEA 2 0.0011
209 BLOOD TRIGLYCERIDES ABNORMAL 1 0.0011
210 ALOPECIA AREATA 2 0.0011
211 EXTRA DOSE ADMINISTERED 46 0.0011
212 DRUG MONITORING PROCEDURE NOT PERFORMED 2 0.0011
213 ANAEMIA OF CHRONIC DISEASE 1 0.0011
214 BONE CONTUSION 1 0.0011
215 VITRITIS 2 0.0011
216 BIOPSY 1 0.0011
217 RENAL FUNCTION TEST ABNORMAL 5 0.0011
218 CEREBRAL TOXOPLASMOSIS 1 0.0011
219 PROCTITIS 3 0.0011
220 GLOMERULAR FILTRATION RATE DECREASED 13 0.0011
221 COR PULMONALE 1 0.0010
222 PRODUCT USE ISSUE 195 0.0010
223 CYTOMEGALOVIRUS CHORIORETINITIS 2 0.0010
224 VITAMIN D DEFICIENCY 10 0.0010
225 BICYTOPENIA 2 0.0010
226 GENE MUTATION 2 0.0010
227 HYPERTRANSAMINASAEMIA 7 0.0010
228 ANORECTAL DISORDER 2 0.0010
229 HEPATITIS C 12 0.0010
230 ADVERSE DRUG REACTION 89 0.0010
231 DILATED CARDIOMYOPATHY 1 0.0010
232 HAND FRACTURE 7 0.0010
233 CORONAVIRUS TEST POSITIVE 1 0.0010
234 HYPERPARATHYROIDISM 2 0.0010
235 CAROTID ARTERIOSCLEROSIS 1 0.0010
236 BRUGADA SYNDROME 1 0.0010
237 BLOOD TESTOSTERONE INCREASED 2 0.0009
238 HYPERPHOSPHATAEMIA 2 0.0009
239 SPUTUM INCREASED 2 0.0009
240 HIGH DENSITY LIPOPROTEIN DECREASED 3 0.0009
241 CYTOGENETIC ABNORMALITY 1 0.0009
242 DISTRACTIBILITY 1 0.0009
243 HERPES VIRUS INFECTION 5 0.0009
244 GRANULOMA 3 0.0009
245 HYPOPNOEA 3 0.0009
246 ECONOMIC PROBLEM 13 0.0009
247 NEPHROPATHY 8 0.0009
248 DEPRESSIVE SYMPTOM 3 0.0009
249 PRURITUS GENITAL 2 0.0008
250 EMOTIONAL DISTRESS 102 0.0008
251 RADIUS FRACTURE 2 0.0008
252 DERMAL CYST 2 0.0008
253 DEPRESSED MOOD 43 0.0008
254 SUFFOCATION FEELING 2 0.0008
255 CHRONIC KIDNEY DISEASE 61 0.0008
256 APPLICATION SITE SCAR 1 0.0008
257 HYPERPARATHYROIDISM SECONDARY 2 0.0008
258 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
259 URINARY TRACT INFECTION BACTERIAL 2 0.0008
260 FOOT FRACTURE 15 0.0008
261 ABORTION MISSED 1 0.0008
262 GASTRIC INFECTION 3 0.0008
263 LACTOSE INTOLERANCE 2 0.0008
264 MEAN CELL VOLUME INCREASED 2 0.0008
265 LOSS OF LIBIDO 7 0.0008
266 ANGINA UNSTABLE 5 0.0008
267 SUSPECTED COUNTERFEIT PRODUCT 3 0.0008
268 PRODUCT DISTRIBUTION ISSUE 7 0.0008
269 DYSSTASIA 22 0.0008
270 CREATININE RENAL CLEARANCE DECREASED 3 0.0007
271 FOOD POISONING 4 0.0007
272 MYCOBACTERIUM AVIUM COMPLEX INFECTION 2 0.0007
273 WRONG PRODUCT ADMINISTERED 5 0.0007
274 ABDOMINAL RIGIDITY 2 0.0007
275 LIP BLISTER 2 0.0007
276 CLUMSINESS 2 0.0007
277 BLOOD PHOSPHORUS INCREASED 2 0.0007
278 CLUSTER HEADACHE 1 0.0007
279 BLOOD TESTOSTERONE DECREASED 5 0.0007
280 CORNEAL ABRASION 1 0.0007
281 LUNG CONSOLIDATION 2 0.0007
282 RENAL IMPAIRMENT 60 0.0007
283 VASCULAR GRAFT 2 0.0007
284 FAECES SOFT 5 0.0007
285 PRODUCT LABEL CONFUSION 4 0.0007
286 DARK CIRCLES UNDER EYES 1 0.0007
287 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 6 0.0007
288 BLOOD CREATINE INCREASED 3 0.0007
289 CONJUNCTIVITIS ALLERGIC 1 0.0007
290 RHINITIS ALLERGIC 3 0.0007
291 QUALITY OF LIFE DECREASED 9 0.0007
292 EXPOSURE DURING PREGNANCY 41 0.0007
293 EMERGENCY CARE 2 0.0007
294 ABDOMINAL HERNIA 3 0.0007
295 PENILE PAIN 2 0.0007
296 CALCULUS URINARY 1 0.0006
297 BLOOD CHOLESTEROL ABNORMAL 3 0.0006
298 DECREASED ACTIVITY 7 0.0006
299 DAYDREAMING 1 0.0006
300 ILLNESS 66 0.0006
301 SECRETION DISCHARGE 8 0.0006
302 BRAIN FOG 10 0.0006
303 MULTIPLE ALLERGIES 5 0.0006
304 ABORTION INDUCED 6 0.0006
305 ABDOMINAL ADHESIONS 2 0.0006
306 LOSS OF THERAPEUTIC RESPONSE 2 0.0006
307 FRUSTRATION TOLERANCE DECREASED 5 0.0006
308 LIVER FUNCTION TEST INCREASED 13 0.0006
309 LIVE BIRTH 5 0.0006
310 SPLENOMEGALY 7 0.0006
311 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
312 ERECTILE DYSFUNCTION 15 0.0006
313 WRIST FRACTURE 7 0.0006
314 PERIPHERAL COLDNESS 8 0.0006
315 PROTEINURIA 11 0.0006
316 NIGHTMARE 20 0.0006
317 MALABSORPTION 3 0.0006
318 GASTRITIS 15 0.0006
319 PAPULE 4 0.0006
320 RENAL PAIN 6 0.0006
321 BLOOD TRIGLYCERIDES INCREASED 10 0.0006
322 SEASONAL ALLERGY 8 0.0006
323 CHEILITIS 3 0.0006
324 BLOOD CREATININE INCREASED 36 0.0006
325 MULTIPLE FRACTURES 9 0.0005
326 FAECALOMA 3 0.0005
327 ANXIETY 155 0.0005
328 TOOTH FRACTURE 6 0.0005
329 HYPERKERATOSIS 3 0.0005
330 BLOOD THYROID STIMULATING HORMONE ABNORMAL 1 0.0005
331 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
332 INJECTION SITE INDURATION 7 0.0005
333 TRANSAMINASES INCREASED 12 0.0005
334 NEURODERMATITIS 2 0.0005
335 PULMONARY MASS 8 0.0005
336 HEPATIC STEATOSIS 10 0.0005
337 CHOLECYSTITIS ACUTE 3 0.0005
338 BOWEL MOVEMENT IRREGULARITY 4 0.0005
339 BLOOD URIC ACID INCREASED 3 0.0005
340 LOW DENSITY LIPOPROTEIN INCREASED 4 0.0005
341 METABOLIC DISORDER 3 0.0005
342 ATROPHY 1 0.0005
343 EOSINOPHILIA 9 0.0005
344 HAEMORRHOIDS 10 0.0005
345 AFFECTIVE DISORDER 4 0.0005
346 HEPATOMEGALY 5 0.0005
347 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
348 LOW BIRTH WEIGHT BABY 4 0.0005
349 HYPERLIPIDAEMIA 6 0.0005
350 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
351 OESOPHAGEAL CANDIDIASIS 2 0.0005
352 MUSCLE HAEMORRHAGE 2 0.0005
353 HEPATITIS CHOLESTATIC 3 0.0005
354 PRODUCT ADMINISTRATION ERROR 10 0.0005
355 END STAGE RENAL DISEASE 9 0.0005
356 POLYURIA 4 0.0005
357 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 3 0.0005
358 ANAL PRURITUS 1 0.0005
359 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
360 DEVICE CONNECTION ISSUE 1 0.0005
361 FACIAL PARALYSIS 4 0.0005
362 TENSION HEADACHE 2 0.0005
363 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
364 OCULAR ICTERUS 2 0.0005
365 TOOTH INJURY 2 0.0005
366 BIPOLAR DISORDER 5 0.0005
367 PRODUCT PREPARATION ISSUE 3 0.0005
368 OSTEONECROSIS 15 0.0005
369 MELANOCYTIC NAEVUS 2 0.0005
370 SPINAL OSTEOARTHRITIS 4 0.0005
371 DIABETIC NEPHROPATHY 1 0.0005
372 COLONOSCOPY 1 0.0005
373 MENINGITIS 3 0.0004
374 CHOLESTATIC LIVER INJURY 1 0.0004
375 POST-TRAUMATIC STRESS DISORDER 3 0.0004
376 ADENOCARCINOMA 1 0.0004
377 IRON DEFICIENCY 2 0.0004
378 URINARY TRACT DISORDER 2 0.0004
379 CHRONIC GASTRITIS 1 0.0004
380 HAEMOGLOBIN INCREASED 2 0.0004
381 RENAL INJURY 13 0.0004
382 CYTOMEGALOVIRUS COLITIS 1 0.0004
383 INCORRECT DOSE ADMINISTERED 98 0.0004
384 DRUG RESISTANCE 11 0.0004
385 BILIRUBIN CONJUGATED INCREASED 1 0.0004
386 YELLOW SKIN 2 0.0004
387 TIBIA FRACTURE 2 0.0004
388 HEPATIC CIRRHOSIS 8 0.0004
389 LOWER LIMB FRACTURE 8 0.0004
390 AFFECT LABILITY 4 0.0004
391 FACE OEDEMA 7 0.0004
392 DERMATITIS BULLOUS 3 0.0004
393 RASH VESICULAR 2 0.0004
394 GUILLAIN-BARRE SYNDROME 2 0.0004
395 NOCTURIA 5 0.0004
396 MAJOR DEPRESSION 3 0.0004
397 UTERINE LEIOMYOMA 3 0.0004
398 BRONCHITIS CHRONIC 1 0.0004
399 THERAPY CHANGE 4 0.0004
400 MUSCULOSKELETAL DISCOMFORT 7 0.0004
401 FOETAL EXPOSURE DURING PREGNANCY 33 0.0004
402 PROTEIN URINE PRESENT 2 0.0004
403 BONE LOSS 6 0.0004
404 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 19 0.0004
405 HEAD DISCOMFORT 7 0.0004
406 DYSPHORIA 2 0.0004
407 DERMATOMYOSITIS 1 0.0004
408 ABDOMINAL INFECTION 1 0.0004
409 CANCER PAIN 1 0.0004
410 GOUT 7 0.0004
411 DISSEMINATED TUBERCULOSIS 1 0.0004
412 ANKLE FRACTURE 6 0.0004
413 CONGENITAL ANOMALY 3 0.0004
414 SKELETAL INJURY 4 0.0004
415 TONSILLITIS 2 0.0004
416 THERAPEUTIC RESPONSE UNEXPECTED 17 0.0004
417 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
418 COMPRESSION FRACTURE 2 0.0004
419 ANAL FISSURE 2 0.0004
420 RHINITIS 3 0.0004
421 SUICIDAL IDEATION 34 0.0004
422 ANAL ABSCESS 2 0.0004
423 PRODUCT RESIDUE PRESENT 2 0.0004
424 BEHAVIOUR DISORDER 2 0.0004
425 ANORGASMIA 1 0.0004
426 MUSCULOSKELETAL DISORDER 7 0.0004
427 OESOPHAGITIS 4 0.0004
428 ESCHERICHIA INFECTION 3 0.0004
429 STAPHYLOCOCCAL INFECTION 12 0.0004
430 ABNORMAL DREAMS 10 0.0004
431 CYTOMEGALOVIRUS INFECTION 6 0.0004
432 DEPRESSION 82 0.0004
433 STREPTOCOCCAL INFECTION 2 0.0004
434 WEIGHT INCREASED 80 0.0004
435 MACULAR OEDEMA 2 0.0004
436 CEREBRAL THROMBOSIS 1 0.0004
437 HOSPITALISATION 54 0.0004
438 NEUROLOGICAL SYMPTOM 2 0.0003
439 CORONARY ARTERY BYPASS 2 0.0003
440 EXERCISE TOLERANCE DECREASED 2 0.0003
441 RALES 2 0.0003
442 SKIN WARM 2 0.0003
443 GASTROENTERITIS 5 0.0003
444 RIB FRACTURE 7 0.0003
445 ENERGY INCREASED 2 0.0003
446 TREATMENT FAILURE 28 0.0003
447 PREMATURE BABY 10 0.0003
448 BONE DISORDER 6 0.0003
449 NEURALGIA 8 0.0003
450 DERMATITIS ACNEIFORM 2 0.0003
451 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
452 RENAL FAILURE 43 0.0003
453 DERMATITIS ALLERGIC 4 0.0003
454 PRODUCT USE COMPLAINT 5 0.0003
455 MUSCLE ATROPHY 4 0.0003
456 OBESITY 5 0.0003
457 WHITE BLOOD CELL COUNT ABNORMAL 2 0.0003
458 PROCTALGIA 2 0.0003
459 NIGHT SWEATS 10 0.0003
460 HEPATITIS ACUTE 2 0.0003
461 SARS-COV-2 TEST POSITIVE 4 0.0003
462 APPETITE DISORDER 2 0.0003
463 ABORTION SPONTANEOUS 12 0.0003
464 ANXIETY DISORDER 1 0.0003
465 GAIT INABILITY 10 0.0003
466 TOXIC SKIN ERUPTION 3 0.0003
467 FEAR 8 0.0003
468 LIVER DISORDER 13 0.0003
469 EAR DISCOMFORT 3 0.0003
470 BONE PAIN 17 0.0003
471 CERVICAL VERTEBRAL FRACTURE 1 0.0003
472 HYPERBILIRUBINAEMIA 3 0.0003
473 DROOLING 2 0.0003
474 BLOOD CREATININE ABNORMAL 1 0.0003
475 RASH 126 0.0003
476 HAIR GROWTH ABNORMAL 2 0.0003
477 LARGE INTESTINE POLYP 2 0.0003
478 DIABETES MELLITUS 22 0.0003
479 NERVOUS SYSTEM DISORDER 9 0.0003
480 APHONIA 4 0.0003
481 CEREBRAL INFARCTION 7 0.0003
482 EXTRASYSTOLES 2 0.0003
483 FOLLICULITIS 3 0.0003
484 MOUTH ULCERATION 6 0.0003
485 SCRATCH 3 0.0003
486 LYMPHADENOPATHY 10 0.0003
487 DRUG ERUPTION 5 0.0003
488 DEVICE PLACEMENT ISSUE 1 0.0003
489 HEPATIC ENZYME INCREASED 19 0.0003
490 PANIC REACTION 2 0.0003
491 RASH PUSTULAR 2 0.0003
492 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
493 BLOOD PHOSPHORUS DECREASED 1 0.0003
494 DENTAL CARIES 3 0.0003
495 SENSITIVE SKIN 2 0.0003
496 PSYCHIATRIC SYMPTOM 2 0.0003
497 ALCOHOL USE 1 0.0003
498 NEOPLASM MALIGNANT 18 0.0003
499 FEELING DRUNK 2 0.0003
500 MALNUTRITION 3 0.0003
501 BONE DENSITY ABNORMAL 1 0.0003
502 OCULAR DISCOMFORT 3 0.0003
503 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9 0.0003
504 ILL-DEFINED DISORDER 16 0.0003
505 CLAVICLE FRACTURE 1 0.0003
506 LIPASE INCREASED 2 0.0003
507 BLOOD CHOLESTEROL INCREASED 12 0.0003
508 CERVIX CARCINOMA 1 0.0003
509 DRUG SCREEN POSITIVE 2 0.0003
510 MENTAL DISORDER 11 0.0003
511 SCIATICA 4 0.0003
512 MATERNAL EXPOSURE DURING PREGNANCY 22 0.0002
513 DECUBITUS ULCER 2 0.0002
514 ANGINA PECTORIS 7 0.0002
515 INSOMNIA 65 0.0002
516 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 2 0.0002
517 PHARYNGITIS 3 0.0002
518 INJECTION SITE DISCOLOURATION 3 0.0002
519 PULMONARY HYPERTENSION 5 0.0002
520 EOSINOPHIL COUNT INCREASED 2 0.0002
521 NEPHROLITHIASIS 11 0.0002
522 POLLAKIURIA 10 0.0002
523 PRODUCT COMPLAINT 6 0.0002
524 DYSPEPSIA 23 0.0002
525 ALCOHOLISM 1 0.0002
526 SKIN HYPERPIGMENTATION 2 0.0002
527 CARDIAC OPERATION 2 0.0002
528 MUSCLE STRAIN 2 0.0002
529 PAIN 142 0.0002
530 PYELONEPHRITIS 2 0.0002
531 BONE CANCER 1 0.0002
532 ABDOMINAL DISTENSION 24 0.0002
533 TOOTH INFECTION 3 0.0002
534 PANCREATITIS 12 0.0002
535 PURPURA 2 0.0002
536 SKIN EXFOLIATION 19 0.0002
537 RASH MACULO-PAPULAR 5 0.0002
538 GASTROOESOPHAGEAL REFLUX DISEASE 18 0.0002
539 HAEMARTHROSIS 2 0.0002
540 OSTEOMYELITIS 4 0.0002
541 NEUROPATHY PERIPHERAL 21 0.0002
542 SKIN LESION 6 0.0002
543 DISEASE COMPLICATION 1 0.0002
544 BRAIN NEOPLASM 2 0.0002
545 HIP FRACTURE 7 0.0002
546 SKIN DISCOLOURATION 10 0.0002
547 ORAL DISCOMFORT 3 0.0002
548 ERYTHEMA MULTIFORME 2 0.0002
549 MIDDLE INSOMNIA 4 0.0002
550 BURNING SENSATION 15 0.0002
551 ARTERIOSCLEROSIS 2 0.0002
552 OSTEOARTHRITIS 9 0.0002
553 INTESTINAL OBSTRUCTION 8 0.0002
554 FRACTURE 4 0.0002
555 COLITIS MICROSCOPIC 1 0.0002
556 PARALYSIS 3 0.0002
557 HERPES ZOSTER 12 0.0002
558 MOBILITY DECREASED 15 0.0002
559 PARAESTHESIA ORAL 3 0.0002
560 HYPERCHOLESTEROLAEMIA 2 0.0002
561 MYALGIA 35 0.0002
562 AUTOIMMUNE DISORDER 2 0.0002
563 PHARYNGEAL SWELLING 2 0.0002
564 RENAL TUBULAR NECROSIS 2 0.0002
565 HYPERTENSION 43 0.0002
566 URINARY INCONTINENCE 6 0.0002
567 HOSPICE CARE 2 0.0002
568 DIABETIC NEUROPATHY 1 0.0002
569 SPINAL FRACTURE 4 0.0002
570 URINARY TRACT INFECTION 34 0.0002
571 GAIT DISTURBANCE 38 0.0002
572 TOOTH ABSCESS 2 0.0002
573 HIP ARTHROPLASTY 3 0.0002
574 LYMPHOMA 3 0.0002
575 COVID-19 34 0.0002
576 HYPOAESTHESIA 29 0.0002
577 TOOTH LOSS 4 0.0002
578 EYE DISCHARGE 2 0.0002
579 PANIC ATTACK 7 0.0002
580 RHABDOMYOLYSIS 8 0.0002
581 APLASTIC ANAEMIA 1 0.0002
582 WEIGHT FLUCTUATION 2 0.0002
583 DYSURIA 7 0.0002
584 DYSPHAGIA 18 0.0002
585 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
586 ANAL FISTULA 1 0.0002
587 MALAISE 81 0.0002
588 RASH PRURITIC 10 0.0002
589 CHOLELITHIASIS 6 0.0002
590 PHOTOSENSITIVITY REACTION 3 0.0002
591 DEAFNESS UNILATERAL 1 0.0002
592 STOMATITIS 11 0.0002
593 TOOTH DISORDER 4 0.0002
594 PAIN IN EXTREMITY 53 0.0002
595 NERVE INJURY 2 0.0002
596 PALPITATIONS 21 0.0002
597 PANCYTOPENIA 10 0.0002
598 EYE PRURITUS 6 0.0002
599 NEPHROPATHY TOXIC 2 0.0002
600 CANDIDA INFECTION 3 0.0002
601 CONDITION AGGRAVATED 54 0.0002
602 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0002
603 DERMATITIS CONTACT 2 0.0002
604 CHOLECYSTECTOMY 2 0.0002
605 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
606 PARANOIA 3 0.0002
607 RENAL DISORDER 8 0.0002
608 PARAESTHESIA 27 0.0002
609 RASH MACULAR 6 0.0002
610 INTENTIONAL PRODUCT MISUSE 15 0.0002
611 SEXUAL DYSFUNCTION 2 0.0002
612 ACUTE KIDNEY INJURY 26 0.0002
613 COVID-19 PNEUMONIA 2 0.0002
614 WHEEZING 10 0.0002
615 BACTERAEMIA 2 0.0002
616 DISEASE RECURRENCE 8 0.0002
617 CHOLECYSTITIS 2 0.0002
618 PRODUCTIVE COUGH 8 0.0002
619 CORONARY ARTERY DISEASE 5 0.0002
620 MENTAL IMPAIRMENT 4 0.0002
621 BURSITIS 2 0.0002
622 BLOOD GLUCOSE ABNORMAL 3 0.0002
623 EYE SWELLING 6 0.0002
624 ILEUS 2 0.0002
625 HEPATIC FUNCTION ABNORMAL 6 0.0002
626 PNEUMONIA ASPIRATION 4 0.0002
627 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
628 DRUG-INDUCED LIVER INJURY 5 0.0002
629 DRUG INTERACTION 25 0.0002
630 INCREASED APPETITE 3 0.0002
631 HEPATIC CYTOLYSIS 2 0.0002
632 FATIGUE 122 0.0002
633 CHOLESTASIS 3 0.0002
634 THROAT IRRITATION 7 0.0002
635 ROTATOR CUFF SYNDROME 2 0.0002
636 INFLAMMATION 8 0.0002
637 SKIN ULCER 4 0.0002
638 BREAST CANCER STAGE III 1 0.0002
639 LACTIC ACIDOSIS 5 0.0002
640 EAR PAIN 3 0.0002
641 APPLICATION SITE VESICLES 1 0.0002
642 ORAL HERPES 3 0.0002
643 DEAFNESS 4 0.0002
644 TINNITUS 7 0.0002
645 IMMUNE SYSTEM DISORDER 2 0.0002
646 CORONAVIRUS INFECTION 1 0.0002
647 PRESCRIBED UNDERDOSE 3 0.0002
648 SKIN DISORDER 5 0.0001
649 SOMNOLENCE 30 0.0001
650 BREAST MASS 1 0.0001
651 BRONCHIECTASIS 1 0.0001
652 INTENTIONAL PRODUCT USE ISSUE 13 0.0001
653 DISTURBANCE IN ATTENTION 8 0.0001
654 COLITIS ISCHAEMIC 1 0.0001
655 BONE MARROW FAILURE 3 0.0001
656 AKATHISIA 2 0.0001
657 CORONARY ARTERY OCCLUSION 2 0.0001
658 PRURITUS 56 0.0001
659 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
660 DRUG INTOLERANCE 14 0.0001
661 DERMATITIS 3 0.0001
662 DEMENTIA 4 0.0001
663 MASS 2 0.0001
664 CARPAL TUNNEL SYNDROME 2 0.0001
665 PERIPHERAL SWELLING 22 0.0001
666 APPLICATION SITE REACTION 1 0.0001
667 SKIN REACTION 2 0.0001
668 IMPAIRED WORK ABILITY 3 0.0001
669 HYPERSENSITIVITY 26 0.0001
670 SUBDURAL HAEMATOMA 2 0.0001
671 SKIN CANCER 3 0.0001
672 HYPERTHYROIDISM 2 0.0001
673 DECREASED APPETITE 32 0.0001
674 PRODUCT DISPENSING ERROR 3 0.0001
675 CRYING 5 0.0001
676 APATHY 2 0.0001
677 SURGERY 8 0.0001
678 WEIGHT DECREASED 38 0.0001
679 ACUTE MYOCARDIAL INFARCTION 4 0.0001
680 ASTHENIA 51 0.0001
681 LABORATORY TEST ABNORMAL 4 0.0001
682 INJECTION SITE MASS 5 0.0001
683 STEVENS-JOHNSON SYNDROME 3 0.0001
684 IMMUNODEFICIENCY 2 0.0001
685 DIARRHOEA 86 0.0001
686 CHROMATURIA 3 0.0001
687 AORTIC ANEURYSM 1 0.0001
688 EPILEPSY 4 0.0001
689 DISSOCIATION 1 0.0001
690 MUSCLE TWITCHING 3 0.0001
691 GENERAL PHYSICAL HEALTH DETERIORATION 15 0.0001
692 LIMB DISCOMFORT 4 0.0001
693 APHTHOUS ULCER 1 0.0001
694 COGNITIVE DISORDER 6 0.0001
695 APNOEA 1 0.0001
696 ACUTE MYELOID LEUKAEMIA 2 0.0001
697 BASAL CELL CARCINOMA 2 0.0001
698 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
699 ANAPHYLACTIC REACTION 7 0.0001
700 OCULAR HYPERAEMIA 6 0.0001
701 ARTHROPATHY 7 0.0001
702 THERAPY INTERRUPTED 9 0.0001
703 ULCER 2 0.0001
704 MIGRAINE 12 0.0001
705 OFF LABEL USE 110 0.0001
706 PREMATURE DELIVERY 2 0.0001
707 ABSCESS 2 0.0001
708 ABDOMINAL DISCOMFORT 21 0.0001
709 BLOOD DISORDER 1 0.0001
710 FLATULENCE 7 0.0001
711 FIBROMYALGIA 3 0.0001
712 HEADACHE 77 0.0001
713 PRODUCT DOSE OMISSION 8 0.0001
714 LIVER INJURY 3 0.0001
715 BRONCHITIS 9 0.0001
716 MANIA 2 0.0001
717 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
718 BACK PAIN 28 0.0001
719 ABDOMINAL PAIN 28 0.0001
720 MUSCLE SPASMS 22 0.0001
721 URINARY RETENTION 4 0.0001
722 DRY SKIN 16 0.0001
723 ATRIAL SEPTAL DEFECT 1 0.0001
724 URTICARIA 20 0.0001
725 TYPE 2 DIABETES MELLITUS 4 0.0001
726 ACNE 9 0.0001
727 ANGER 4 0.0001
728 HEPATITIS 3 0.0001
729 THERAPY CESSATION 6 0.0001
730 SCAR 2 0.0001
731 HAEMATURIA 4 0.0001
732 INFLUENZA 13 0.0001
733 ABDOMINAL PAIN UPPER 24 0.0001
734 MEMORY IMPAIRMENT 16 0.0001
735 IRRITABILITY 7 0.0001
736 BLOOD MAGNESIUM DECREASED 1 0.0001
737 ARTHRALGIA 48 0.0001
738 RESPIRATORY TRACT INFECTION 3 0.0001
739 NAUSEA 91 0.0001
740 ECZEMA 6 0.0001
741 MUSCULOSKELETAL STIFFNESS 10 0.0001
742 INJURY 8 0.0001
743 EAR INFECTION 3 0.0001
744 FEELING ABNORMAL 27 0.0001
745 CEREBRAL HAEMORRHAGE 4 0.0001
746 MYELOSUPPRESSION 4 0.0001
747 BLOOD BILIRUBIN INCREASED 3 0.0001
748 THROAT TIGHTNESS 3 0.0001
749 LIMB INJURY 3 0.0001
750 ANAEMIA 21 0.0001
751 VISION BLURRED 15 0.0001
752 CONJUNCTIVITIS 2 0.0001
753 AMNESIA 7 0.0001
754 HAEMOPTYSIS 3 0.0001
755 SWELLING FACE 7 0.0001
756 THINKING ABNORMAL 2 0.0001
757 DEFORMITY 1 0.0001
758 CEREBROVASCULAR ACCIDENT 18 0.0001
759 BLOOD URINE PRESENT 2 0.0001
760 BLOOD PRESSURE DECREASED 7 0.0001
761 GASTRIC ULCER 2 0.0001
762 RENAL CANCER 5 0.0001
763 HYPERSOMNIA 3 0.0001
764 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
765 SEROTONIN SYNDROME 2 0.0001
766 DRUG INEFFECTIVE 137 0.0001
767 ERUCTATION 2 0.0001
768 LIVER FUNCTION TEST ABNORMAL 3 0.0001
769 NASOPHARYNGITIS 19 0.0001
770 CHILLS 12 0.0001
771 COELIAC DISEASE 1 0.0001
772 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
773 ALOPECIA 20 0.0001
774 DISABILITY 2 0.0001
775 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
776 BLOOD PRESSURE ABNORMAL 2 0.0001
777 UPPER LIMB FRACTURE 2 0.0001
778 LEUKOPENIA 5 0.0001
779 JOINT SWELLING 12 0.0001
780 APHASIA 3 0.0001
781 LACRIMATION INCREASED 3 0.0001
782 SLEEP DISORDER 7 0.0001
783 SUICIDE ATTEMPT 6 0.0001
784 FEEDING DISORDER 2 0.0001
785 TASTE DISORDER 2 0.0001
786 DISCOMFORT 6 0.0001
787 DRUG LEVEL DECREASED 1 0.0001
788 BLOOD PRESSURE INCREASED 15 0.0001
789 LUNG NEOPLASM MALIGNANT 4 0.0001
790 GYNAECOMASTIA 3 0.0001
791 MUSCULAR WEAKNESS 11 0.0001
792 ROAD TRAFFIC ACCIDENT 4 0.0001
793 MUSCULOSKELETAL PAIN 5 0.0001
794 HEAD INJURY 3 0.0001
795 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
796 BODY HEIGHT DECREASED 1 0.0001
797 POOR QUALITY SLEEP 2 0.0001
798 HOT FLUSH 7 0.0001
799 FAECES DISCOLOURED 2 0.0001
800 PRODUCT PRESCRIBING ISSUE 2 0.0001
801 PRODUCT STORAGE ERROR 8 0.0001
802 ASPIRATION 1 0.0001
803 EYE DISORDER 3 0.0001
804 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
805 ANGIOEDEMA 4 0.0001
806 EXPIRED PRODUCT ADMINISTERED 3 0.0001
807 FUNGAL INFECTION 3 0.0001
808 MEDICATION ERROR 5 0.0001
809 HEPATOTOXICITY 2 0.0001
810 INJECTION SITE PRURITUS 6 0.0001
811 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
812 SNEEZING 2 0.0001
813 CHEST DISCOMFORT 9 0.0001
814 PRODUCT AVAILABILITY ISSUE 2 0.0001
815 GASTRIC DISORDER 3 0.0001
816 DEATH 75 0.0001
817 LETHARGY 5 0.0001
818 EYE IRRITATION 5 0.0001
819 PYREXIA 30 0.0001
820 CONFUSIONAL STATE 14 0.0001
821 DIZZINESS 43 0.0001
822 HAEMORRHAGE 9 0.0001
823 HYPERKALAEMIA 3 0.0001
824 VOMITING 40 0.0001
825 PRODUCT PRESCRIBING ERROR 2 0.0001
826 ACCIDENT 1 0.0001
827 BLOOD GLUCOSE DECREASED 4 0.0001
828 CONSTIPATION 18 0.0001
829 ADRENAL INSUFFICIENCY 1 0.0001
830 UNDERDOSE 6 0.0001
831 CYTOPENIA 1 0.0001
832 LUNG DISORDER 4 0.0001
833 BALANCE DISORDER 7 0.0001
834 ABNORMAL WEIGHT GAIN 1 0.0001
835 CYST 1 0.0001
836 PNEUMONIA 26 0.0001
837 AGEUSIA 2 0.0001
838 DRY EYE 4 0.0001
839 HALLUCINATION 6 0.0001
840 CELLULITIS 4 0.0001
841 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
842 FLUID RETENTION 4 0.0001
843 SEIZURE 9 0.0001
844 RHINORRHOEA 5 0.0001
845 NO ADVERSE EVENT 14 0.0001
846 HAEMATOMA 2 0.0001
847 PLASMA CELL MYELOMA 3 0.0001
848 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
849 SEDATION 2 0.0001
850 APPLICATION SITE ERYTHEMA 2 0.0001
851 ARTHRITIS 6 0.0001
852 BEDRIDDEN 1 0.0001
853 CHEST PAIN 14 0.0001
854 ADVERSE REACTION 1 0.0001
855 PLATELET COUNT DECREASED 8 0.0001
856 MENSTRUATION IRREGULAR 2 0.0001
857 THROMBOSIS 6 0.0001
858 DRY MOUTH 6 0.0001
859 BLINDNESS 3 0.0001
860 ACUTE HEPATIC FAILURE 1 0.0001
861 CONTUSION 7 0.0001
862 DIVERTICULITIS 2 0.0001
863 PROCEDURAL PAIN 2 0.0001
864 COORDINATION ABNORMAL 1 0.0001
865 NECK PAIN 4 0.0001
866 BLISTER 4 0.0001
867 BLOOD TEST ABNORMAL 1 0.0001
868 EYE PAIN 4 0.0001
869 HEART RATE INCREASED 7 0.0001
870 PAIN IN JAW 2 0.0001
871 DIALYSIS 1 0.0001
872 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
873 LOSS OF CONSCIOUSNESS 9 0.0001
874 SYNCOPE 7 0.0001
875 RECTAL HAEMORRHAGE 3 0.0001
876 CARDIOGENIC SHOCK 1 0.0001
877 HYPOACUSIS 3 0.0001
878 DYSPHONIA 4 0.0001
879 ASCITES 2 0.0001
880 PSYCHOTIC DISORDER 2 0.0001
881 TACHYCARDIA 6 0.0001
882 BLOOD POTASSIUM DECREASED 2 0.0001
883 TREMOR 11 0.0001
884 FALL 22 0.0001
885 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
886 INJECTION SITE PAIN 20 0.0001
887 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
888 HYPOKALAEMIA 3 0.0001
889 DEVICE RELATED INFECTION 1 0.0001
890 EMOTIONAL DISORDER 2 0.0001
891 FEMUR FRACTURE 2 0.0001
892 COUGH 18 0.0001
893 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 13 0.0001
894 CARDIAC DISORDER 6 0.0001
895 SWOLLEN TONGUE 2 0.0001
896 CYANOSIS 1 0.0001
897 MOOD SWINGS 2 0.0001
898 INJECTION SITE BRUISING 5 0.0001
899 CARDIAC FAILURE 5 0.0001
900 PROSTATE CANCER 5 0.0001
901 ASTHMA 7 0.0001
902 HYPOGLYCAEMIA 3 0.0001
903 BLOOD POTASSIUM INCREASED 1 0.0001
904 DEEP VEIN THROMBOSIS 4 0.0001
905 BACK DISORDER 1 0.0001
906 PRODUCT USE IN UNAPPROVED INDICATION 15 0.0001
907 DYSPNOEA 34 0.0001
908 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
909 FLUSHING 6 0.0001
910 NEUTROPENIA 8 0.0001
911 NERVOUSNESS 3 0.0001
912 MYOCARDIAL INFARCTION 10 0.0001
913 COLD SWEAT 1 0.0001
914 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
915 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
916 GASTROINTESTINAL DISORDER 5 0.0001
917 OEDEMA 3 0.0001
918 RESTLESSNESS 2 0.0001
919 AGITATION 4 0.0001
920 OROPHARYNGEAL PAIN 5 0.0001
921 DYSGEUSIA 4 0.0001
922 BACTERIAL INFECTION 1 0.0001
923 ERYTHEMA 11 0.0001
924 DYSPNOEA EXERTIONAL 2 0.0001
925 INJECTION SITE SWELLING 4 0.0001
926 DISORIENTATION 2 0.0001
927 OEDEMA PERIPHERAL 6 0.0000
928 BODY TEMPERATURE INCREASED 1 0.0000
929 FEELING HOT 3 0.0000
930 SINUSITIS 5 0.0000
931 INFECTION 7 0.0000
932 HYPERHIDROSIS 6 0.0000
933 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
934 VAGINAL HAEMORRHAGE 2 0.0000
935 SEPTIC SHOCK 2 0.0000
936 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
937 DEHYDRATION 6 0.0000
938 THROMBOCYTOPENIA 5 0.0000
939 APPLICATION SITE PRURITUS 1 0.0000
940 ADVERSE EVENT 4 0.0000
941 SWELLING 4 0.0000
942 BLOOD GLUCOSE INCREASED 8 0.0000
943 ARRHYTHMIA 2 0.0000
944 RASH ERYTHEMATOUS 2 0.0000
945 TOXICITY TO VARIOUS AGENTS 7 0.0000
946 INTERSTITIAL LUNG DISEASE 2 0.0000
947 RESPIRATORY FAILURE 3 0.0000
948 VISUAL IMPAIRMENT 5 0.0000
949 AGGRESSION 2 0.0000
950 ABDOMINAL PAIN LOWER 1 0.0000
951 CARDIOVASCULAR DISORDER 1 0.0000
952 INFLUENZA LIKE ILLNESS 3 0.0000
953 HAEMATOCHEZIA 2 0.0000
954 PRODUCT SUBSTITUTION ISSUE 2 0.0000
955 CATARACT 2 0.0000
956 THERAPEUTIC RESPONSE DECREASED 2 0.0000
957 VERTIGO 2 0.0000
958 INTENTIONAL OVERDOSE 2 0.0000
959 ATRIAL FIBRILLATION 3 0.0000
960 INJECTION SITE REACTION 2 0.0000
961 DEVICE USE ERROR 1 0.0000
962 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
963 C-REACTIVE PROTEIN INCREASED 1 0.0000
964 ACCIDENTAL OVERDOSE 1 0.0000
965 ABNORMAL BEHAVIOUR 1 0.0000
966 CARDIAC ARREST 2 0.0000
967 INJECTION SITE ERYTHEMA 3 0.0000
968 DRUG ABUSE 2 0.0000
969 OVERDOSE 5 0.0000
970 DEVICE LEAKAGE 1 0.0000
971 DEVICE DISLOCATION 1 0.0000
972 COLITIS ULCERATIVE 1 0.0000
973 COMA 1 0.0000
974 HYPOTENSION 4 0.0000
975 HAEMOGLOBIN DECREASED 2 0.0000
976 DERMATITIS ATOPIC 1 0.0000
977 BRADYCARDIA 1 0.0000
978 RHEUMATOID ARTHRITIS 2 0.0000
979 BLADDER CANCER 1 0.0000
980 CARDIAC FAILURE CONGESTIVE 1 0.0000
981 DRUG DEPENDENCE 2 0.0000
982 COMPLETED SUICIDE 1 0.0000
983 BREAST CANCER 1 0.0000
984 DISEASE PROGRESSION 1 0.0000